BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33474881)

  • 1. Epigenetic therapeutic strategies in pancreatic cancer.
    Orlacchio A; Muzyka S; Gonda TA
    Int Rev Cell Mol Biol; 2024; 383():1-40. PubMed ID: 38359967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma.
    Evan T; Wang VM; Behrens A
    Oncogene; 2022 Oct; 41(42):4686-4695. PubMed ID: 36088504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular.
    Li O; Li L; Sheng Y; Ke K; Wu J; Mou Y; Liu M; Jin W
    Cancer Lett; 2023 Oct; 574():216391. PubMed ID: 37714257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges.
    Srilatha M; Malla R; Adem MP; Foote JB; Nagaraju GP
    Semin Cancer Biol; 2023 Dec; 97():12-20. PubMed ID: 37926347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma.
    Shen X; Niu N; Xue J
    J Transl Int Med; 2023 Dec; 11(4):322-329. PubMed ID: 38130635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-Ribosylation Factor 6 Pathway Acts as a Key Executor of Mesenchymal Tumor Plasticity.
    Hashimoto A; Hashimoto S
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk of nervous and immune systems in pancreatic cancer.
    Huang FF; Cui WH; Ma LY; Chen Q; Liu Y
    Front Cell Dev Biol; 2023; 11():1309738. PubMed ID: 38099290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environment Influences Tumor Progression and Transcriptional Subtype in a New Model of Pancreatic Cancer.
    Pickering KA; Morton JP
    Cancer Discov; 2020 Oct; 10(10):1448-1450. PubMed ID: 33004478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insights into the biology of pancreatic cancer.
    Yao W; Maitra A; Ying H
    EBioMedicine; 2020 Mar; 53():102655. PubMed ID: 32139179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling.
    Islam MM; Goertzen A; Singh PK; Saha R
    iScience; 2022 Jun; 25(6):104483. PubMed ID: 35712079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer and adaptive metabolism in a nutrient-deficient environment.
    Słotwiński R; Słotwińska SM
    Cent Eur J Immunol; 2021; 46(3):388-394. PubMed ID: 34764812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype.
    Swayden M; Iovanna J; Soubeyran P
    Heliyon; 2018 Dec; 4(12):e01055. PubMed ID: 30582059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment.
    Li Y; Zhang J; Xu J; Liu S
    Front Oncol; 2021; 11():759376. PubMed ID: 34976805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives.
    Wu Y; Zhang C; Jiang K; Werner J; Bazhin AV; D'Haese JG
    Front Oncol; 2020; 10():621937. PubMed ID: 33520728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advancement in Atypical Lipomatous Tumor Research.
    Mashima E; Sawada Y; Nakamura M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy evaluation of nilotinib treatment in different genomic subtypes of gastrointestinal stromal tumors: A meta-analysis and systematic review.
    Zhao Z; Zhang J; Zhang W; Tan S; Wei HT; You J; Guo S; Wang J; Chen P; Xu Y; Zong L
    Curr Probl Cancer; 2021 Jun; 45(3):100705. PubMed ID: 33495025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas.
    Matter MS; Chijioke O; Savic S; Bubendorf L
    Transl Lung Cancer Res; 2020 Dec; 9(6):2645-2655. PubMed ID: 33489824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Review of Metabolic Stress and Development of Pancreatic Cancer].
    Li JT; Lei MZ; Lei QY; Yin M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 52(1):5-10. PubMed ID: 33474881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
    Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.